Open Access
- 25 June 2012
- journal article
- review article
- Published by Springer Nature in Head & Neck Oncology
- Vol. 4 (1) , 39
Abstract
Background: Thyroid carcinoma generally responds well to treatment and spinal metastasis is an uncommon feature. Many studies have looked at the management of spinal metastasis and proposed treatments, plans and algorithms. These range from well-established methods to potentially novel alternatives including bisphosphonates and vascular endothelial growth factor (VEGF) therapy, amongst others. The purposes of this systematic review of the literature are twofold. Firstly we sought to analyse the proposed management options in the literature. Then, secondly, we endeavoured to make recommendations that might improve the prognosis of patients with spinal metastasis from thyroid carcinomas. Methods: We conducted an extensive electronic literature review regarding the management of spinal metastasis of thyroid cancer. Results: We found that there is a tangible lack of studies specifically analysing the management of spinal metastasis in thyroid cancer. Our results show that there are palliative and curative options in the management of spinal metastasis, in the forms of radioiodine ablation, surgery, selective embolisation, bisphosphonates and more recently the VEGF receptor targets. Conclusions: The management of spinal metastasis from thyroid cancer should be multi-disciplinary. There is an absence; it seems, of a definitive protocol for treatment. Research shows increased survival with 131I avidity and complete bone metastasis resection. Early detection and treatment therefore are crucial. Studies suggest in those patients below the age of 45 years that treatment should be aggressive, and aim for cure. In those patients in whom curative treatment is not an option, palliative treatments are available.Keywords
This publication has 53 references indexed in Scilit:
- Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III TrialJournal of Clinical Oncology, 2012
- Diagnosis and Management of Metastatic Cervical Spine TumorsOrthopedic Clinics of North America, 2012
- Thyroid Cancer Incidence Patterns in the United States by Histologic Type, 1992–2006Thyroid®, 2011
- Spine metastases: Current treatments and future directionsEuropean Journal of Cancer, 2010
- Treatment with Tyrosine Kinase Inhibitors for Patients with Differentiated Thyroid Cancer: the M. D. Anderson ExperienceThe Journal of Clinical Endocrinology & Metabolism, 2010
- Phase II Trial of Sorafenib in Metastatic Thyroid CancerJournal of Clinical Oncology, 2009
- International patterns and trends in thyroid cancer incidence, 1973–2002Cancer Causes & Control, 2008
- New therapeutic approaches for metastatic thyroid carcinomaThe Lancet Oncology, 2007
- Mechanisms of Bone MetastasisNew England Journal of Medicine, 2004
- THE FUNCTION OF THE VERTEBRAL VEINS AND THEIR ROLE IN THE SPREAD OF METASTASESAnnals of Surgery, 1940